RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Dermal Ulcers Therapy Area Pipeline Report
Nov 2010 - 72 pages - $1,495
Diabetic Foot Ulcers - Pipeline Review, Q1 2011
Mar 2011 - 53 pages - $500
Diabetic Ulcers Therapy Area Pipeline Report
Nov 2010 - 106 pages - $1,495
Ulcers Therapy Area Pipeline Report
Nov 2010 - 590 pages - $1,495
Skin Ulcers Global Clinical Trials Review, Q1, 2011
Mar 2011 - 23 pages - $1,000
Phage Biotechnology Corporation – Product Pipeline Review – Q4 2010
Dec 2010 - 25 pages - $500
Venous Ulcers Global Clinical Trials Review, Q2, 2011
May 2011 - 36 pages - $1,000
Mouth Ulcers Global Clinical Trials Review, Q1, 2011
Mar 2011 - 31 pages - $1,000
Allergic Corneal Marginal Ulcers Global Clinical Trials Review, Q1, 2011
Apr 2011 - 22 pages - $1,000
Mouth Ulcers - Pipeline Review, Q2 2011
Jun 2011 - 29 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Therapeutic target
Dermatological del
Dermal ulcers del
Development phase
Phase II del

Browse By

Industry sector
Assay systems
Diagnostic test systems
Gene therapy
Human diagnostics
Human therapeutics
Nanotechnology
Other
Research supplies
Stem cells

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us